Cipher Pharmaceuticals Inc. (TSE:CPH) Director Sells C$47,215.00 in Stock

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) Director Harold Morton Wolkin sold 3,500 shares of the company’s stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of C$13.49, for a total transaction of C$47,215.00.

Cipher Pharmaceuticals Stock Down 1.3 %

Shares of TSE CPH opened at C$12.16 on Thursday. The company has a quick ratio of 2.67, a current ratio of 2.00 and a debt-to-equity ratio of 41.22. The business’s 50 day moving average is C$12.82 and its two-hundred day moving average is C$14.34. Cipher Pharmaceuticals Inc. has a 52-week low of C$7.90 and a 52-week high of C$19.69. The firm has a market cap of C$218.31 million, a price-to-earnings ratio of 13.43 and a beta of 1.20.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company’s geographical segments include Canada and the United States.